Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma
Year: 2004
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: University of Vienna, Medical University of Vienna
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2027362911
